Ascentage Pharma saw its share price surge 57% during the first day of trading in Hong Kong before closing up 9.9%, following a heavily oversubscribed HK$416.6 million ($53 million) IPO.
The Chinese drug developer sold 12.18 million shares for HK$34.20 apiece, according to a filing. The Hong Kong portion of the offering was enlarged after subscriptions exceeded the available volume of...
Kalihulian - a China-based digital logistics platform that offers an Uber-style service for cargo freight - has raised RMB100 million ($14 million) in Series A funding led by Sino-Ocean Capital, an investment arm of property developer Sino-Ocean Group.
Neuron Mobility, a Singapore-based e-scooter company, has secured a $18.5 million Series A round led by Australia’s Square Peg Capital and US-based GSR Ventures.
Vertex Ventures, a VC arm of Singapore’s Temasek Holdings, has received commitments of $180 million from Japanese investors for a fund-of-funds that will support its global portfolio of VC vehicles.
Private markets investors in Asia have outperformed their developed markets peers in four out of the last six years in terms of IRR, with the once substantial gap in median distributions also narrowing, according to analysis by Hamilton Lane.